Synthetic Biologics (NYSE Amex: SYN) is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Synthetic Biologics is developing, or has partnered the development of, product candidates to treat pulmonary arterial hypertension (PAH), relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis (ALS).
-
Companies To Watch
ACCP.OB 1.28 -0.04
ALXA 0.51 -0.02
ARDM.OB 0.14 +0.015
CGNH.OB 0.46 +0.02
CNDO 6.85 +0.07
CRMD 0.36 +0.0099
DARA 2.13 -0.23
DND.TO 1.03 -0.20
DVAX 4.04 -0.09
GLPG.BR 11.48 +0.03
KERX 3.04 -0.01
LPTN.OB 0.8411 -0.0789
MEDW 14.51 -0.37
PBIO 0.73 +0.03
RPBC.PK 0.004 0.00
SNWV.OB 0.40 -0.05
SYN 2.36 -0.19
THLD 6.03 +1.02
VTUS 9.47 +0.04
XXII.OB 0.401 -0.189
ZIOP 4.90 -0.11
2012-02-22 15:36
